Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12620000198921Phase 3Recruiting
Phase 3, randomised, open-label trial of dexmedetomidine, ketamine, lidocaine, propofol, desflurane and 2 more in obesity (2 arms), sponsored by Department of Anaesthesia. Primary endpoint: Postoperative opioid requirement. Started Nov 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12620000198921.